UBS analyst Danielle Antalffy lowered the firm’s price target on Sight Sciences (SGHT) to $5 from $5.50 and keeps a Buy rating on the shares.
Thales has revealed that it has already sold thousands of its Xtraim weapon sights, including sales late in-2024, and that it is now in service with two NATO countries along with one country in the ...
Lake Street lowered the firm’s price target on Sight Sciences (SGHT) to $3 from $5 and keeps a Hold rating on the shares after the company ...